Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery - Trial NCT06095882
Access comprehensive clinical trial information for NCT06095882 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Not yet recruiting. The study focuses on Cervical Cancer. Target enrollment is 180 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Qilu Hospital of Shandong University
Timeline & Enrollment
N/A
Nov 01, 2023
Nov 01, 2025
Primary Outcome
The incidence of urinary retention
Summary
Urinary retention is one of the most common complications of radical hysterectomy in patients
 with cervical cancer, with an incidence of 26-53% depending on the diagnostic criteria.
 
 The most common method to prevent urinary retention after radical hysterectomy is continuous
 catheterization, but up to 14.5% of patients need continuous catheterization for more than 4
 weeks, because catheterization is an invasive procedure, increasing the risk of urinary tract
 infection, and long-term postoperative retention of urinary catheter caused by edema of the
 vesicourethral sphincter and urethral glands. Obstruction of bladder outlet caused by
 increased urethral outflow resistance may also lead to postoperative urinary retention, thus
 forming a vicious cycle and aggravating urinary retention.
 
 In our previous retrospective analysis, it was confirmed that acupuncture and moxibustion
 were effective in restoring bladder function after radical hysterectomy. Compared with the
 control group, the incidence of urinary retention in patients receiving acupuncture and
 moxibustion was reduced from 44.17% to 24.17%, and no serious adverse reactions occurred, and
 the patients had good tolerance. We plan to conduct further randomized controlled studies to
 confirm this.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06095882
Non-Device Trial

